- 優先名称
- Erythromycin salnacedin
- IUPAC
- (2R)-2-acetamido-3-(2-hydroxybenzoyl)sulfanylpropanoic acid;(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;dihydrate
名称と別名
Erythromycin salnacedin dihydrateERYTHROMYCIN SALNACEDINErythromycin salnacedin [USAN]149908-23-6G-101, SCY-ErVMA8F29A76Erythromycin salnacedin (USAN)Erythromycin, compound with N-acetyl-L-cysteine 2-hydroxybenzoate (ester) (1:1), dihydrateErythromycin, compound with N-acetyl-L-cysteine salicylate (ester) (1:1), dihydrateUNII-VMA8F29A76SCY-ERSCHEMBL666616
名称をさらに表示
G-101-SCY-ERERYTHROMYCIN SALNACEDIN HYDRATE(2R)-2-acetamido-3-(2-hydroxybenzoyl)sulfanylpropanoic acid;(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;dihydrateG-101D04054ERYTHROMYCIN SALNACEDIN DIHYDRATE [WHO-DD]Q27291899
データベース識別子
- PubChem CID
- 20055320
- UNII
- VMA8F29A76